Skip to main content
. 2022 Jan;12(1):608–617. doi: 10.21037/qims-21-143

Table 1. Clinicopathological characteristics of patients in the rHGP and non-rHGP group.

Variables rHGP (n=12) Non-rHGP (n=41) P value
Gender, n (%) >0.999
   Male 5 (41.67) 17 (41.46)
   Female 7 (58.33) 24 (58.54)
Age (year) 60.78±10.25 57.92±8.11 0.323
Interval between MRI and surgery (day) 8.42±5.00 9.20±5.53 0.663
Location of primary tumor, n (%) >0.999
   Left-sided 9 (75.00) 31 (75.61)
   Right-sided 3 (25.00) 10 (24.39)
Pathology of primary tumor, n (%) 0.738
   Papillary adenocarcinoma 3 (25.00) 6 (14.63)
   High and moderate differentiated adenocarcinoma 6 (50.00) 25 (60.98)
   Low differentiated adenocarcinoma 3 (25.00) 9 (21.95)
   Micropapillary carcinoma 0 (0.00) 1 (2.44)
T stage, n (%) 0.414
   T2 0 (0.00) 3 (7.32)
   T3 4 (33.33) 7 (17.07)
   T4 8 (66.67) 31 (75.61)
N stage, n (%) 0.648
   N0 5 (41.67) 21 (51.22)
   N1 5 (41.67) 16 (39.02)
   N2 2 (16.67) 4 (9.76)

Non-rHGP: including the desmoplastic histopathological growth pattern and the pushing histopathological growth pattern. rHGP, replacement histopathological growth pattern; MRI, magnetic resonance imaging.